High-sensitivity immunoassays, including enzyme-linked immunosorbent assays (ELISA) and chemiluminescent immunoassays (CLIA), require low background signal, minimal nonspecific binding, and consistent antibody performance to detect low-abundance biomarkers.
Recombinant human serum albumin (rHSA) can be evaluated as an ELISA blocking agent, antibody diluent, and assay reagent stabilizer. As an animal-origin-free alternative to bovine serum albumin (BSA) and plasma-derived human serum albumin (HSA), recombinant albumin offers a defined protein source for optimizing blocking buffers, reducing surface adsorption, and evaluating signal-to-noise ratios.
InVitria’s Optibumin® 25 and Exbumin® provide recombinant albumin options for developing sensitive, reproducible immunoassays, including ELISA and selected chemiluminescent detection platforms.